首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   240503篇
  免费   26822篇
  国内免费   7810篇
电工技术   11906篇
技术理论   14篇
综合类   11214篇
化学工业   51090篇
金属工艺   10835篇
机械仪表   12655篇
建筑科学   18040篇
矿业工程   4942篇
能源动力   6596篇
轻工业   19320篇
水利工程   3485篇
石油天然气   11114篇
武器工业   1345篇
无线电   31390篇
一般工业技术   36423篇
冶金工业   11476篇
原子能技术   2114篇
自动化技术   31176篇
  2024年   881篇
  2023年   3262篇
  2022年   5834篇
  2021年   8113篇
  2020年   7041篇
  2019年   7720篇
  2018年   8108篇
  2017年   9239篇
  2016年   9152篇
  2015年   10817篇
  2014年   12977篇
  2013年   16603篇
  2012年   14592篇
  2011年   15973篇
  2010年   13975篇
  2009年   13699篇
  2008年   12713篇
  2007年   12163篇
  2006年   12341篇
  2005年   10864篇
  2004年   7775篇
  2003年   6970篇
  2002年   6418篇
  2001年   5750篇
  2000年   5857篇
  1999年   6049篇
  1998年   5327篇
  1997年   4388篇
  1996年   3973篇
  1995年   3326篇
  1994年   2786篇
  1993年   2202篇
  1992年   1713篇
  1991年   1293篇
  1990年   1029篇
  1989年   880篇
  1988年   687篇
  1987年   503篇
  1986年   401篇
  1985年   340篇
  1984年   215篇
  1983年   202篇
  1982年   163篇
  1981年   148篇
  1980年   133篇
  1979年   97篇
  1978年   65篇
  1977年   65篇
  1976年   78篇
  1975年   40篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Ovarian cancer is the most lethal gynecologic malignancy in the United States. Some patients affected by ovarian cancers often present genome instability with one or more of the defects in DNA repair pathways, particularly in homologous recombination (HR), which is strictly linked to mutations in breast cancer susceptibility gene 1 (BRCA 1) or breast cancer susceptibility gene 2 (BRCA 2). The treatment of ovarian cancer remains a challenge, and the majority of patients with advanced-stage ovarian cancers experience relapse and require additional treatment despite initial therapy, including optimal cytoreductive surgery (CRS) and platinum-based chemotherapy. Targeted therapy at DNA repair genes has become a unique strategy to combat homologous recombination-deficient (HRD) cancers in recent years. Poly (ADP-ribose) polymerase (PARP), a family of proteins, plays an important role in DNA damage repair, genome stability, and apoptosis of cancer cells, especially in HRD cancers. PARP inhibitors (PARPi) have been reported to be highly effective and low-toxicity drugs that will tremendously benefit patients with HRD (i.e., BRCA 1/2 mutated) epithelial ovarian cancer (EOC) by blocking the DNA repair pathways and inducing apoptosis of cancer cells. PARP inhibitors compete with NAD+ at the catalytic domain (CAT) of PARP to block PARP catalytic activity and the formation of PAR polymers. These effects compromise the cellular ability to overcome DNA SSB damage. The process of HR, an essential error-free pathway to repair DNA DSBs during cell replication, will be blocked in the condition of BRCA 1/2 mutations. The PARP-associated HR pathway can also be partially interrupted by using PARP inhibitors. Grossly, PARP inhibitors have demonstrated some therapeutic benefits in many randomized phase II and III trials when combined with the standard CRS for advanced EOCs. However, similar to other chemotherapy agents, PARP inhibitors have different clinical indications and toxicity profiles and also face drug resistance, which has become a major challenge. In high-grade epithelial ovarian cancers, the cancer cells under hypoxia- or drug-induced stress have the capacity to become polyploidy giant cancer cells (PGCCs), which can survive the attack of chemotherapeutic agents and start endoreplication. These stem-like, self-renewing PGCCs generate mutations to alter the expression/function of kinases, p53, and stem cell markers, and diploid daughter cells can exhibit drug resistance and facilitate tumor growth and metastasis. In this review, we discuss the underlying molecular mechanisms of PARP inhibitors and the results from the clinical studies that investigated the effects of the FDA-approved PARP inhibitors olaparib, rucaparib, and niraparib. We also review the current research progress on PARP inhibitors, their safety, and their combined usage with antiangiogenic agents. Nevertheless, many unknown aspects of PARP inhibitors, including detailed mechanisms of actions, along with the effectiveness and safety of the treatment of EOCs, warrant further investigation.  相似文献   
992.
陈西敏 《规划师》2008,24(6):50-52
<中华人民共和国城乡规划法>的颁布实施带来了我国城乡规划体系内外环境的革新,为制度的建设与完善提供了契机,但新规划法仍存在立法遗憾.在实施办法上,可将<土地法>约定的土地资源管制与<规划法>约定的使用性质管制分离,将平面集权式的用地管理体系调整为立体分权式的用地管理体系;建立包括城乡规划编制权,审批权、许可权、监督权,司法权在内的相互制约的五公权制衡制度.  相似文献   
993.
Mycoplasma hyopneumoniae (Mhp), the primary pathogen causing Mycoplasma pneumonia of swine (MPS), brings massive economic losses worldwide. Genomic variability and post-translational protein modification can enhance the immune evasion of Mhp, which makes MPS prone to recurrent outbreaks on farms, even with vaccination or other treatments. The reverse vaccinology pipeline has been developed as an attractive potential method for vaccine development due to its high efficiency and applicability. In this study, a multi-epitope vaccine for Mhp was developed, and its immune responses were evaluated in mice and piglets. Genomic core proteins of Mhp were retrieved through pan-genome analysis, and four immunodominant antigens were screened by host homologous protein removal, membrane protein screening, and virulence factor identification. One immunodominant antigen, AAV27984.1 (membrane nuclease), was expressed by E. coli and named rMhp597. For epitope prioritization, 35 B-cell-derived epitopes were identified from the four immunodominant antigens, and 10 MHC-I and 6 MHC-II binding epitopes were further identified. The MHC-I/II binding epitopes were merged and combined to produce recombinant proteins MhpMEV and MhpMEVC6His, which were used for animal immunization and structural analysis, respectively. Immunization of mice and piglets demonstrated that MhpMEV could induce humoral and cellular immune responses. The mouse serum antibodies could detect all 11 synthetic epitopes, and the piglet antiserum suppressed the nuclease activity of rMhp597. Moreover, piglet serum antibodies could also detect cultured Mhp strain 168. In summary, this study provides immunoassay results for a multi-epitope vaccine derived from the reverse vaccinology pipeline, and offers an alternative vaccine for MPS.  相似文献   
994.
995.
设计一种能够使工件按一定的技术要求准确定位和牢固夹紧的杠杆夹具,提高产品质量和生产效率。  相似文献   
996.
陈炯 《钢结构》2008,23(12):44-49
在文献[1]的基本思路和初步结果的基础上,对钢结构中按弹性准则设计的截面,根据腹板屈曲与否对其进行分级;改进、完善和细化了框架截面等级与地震作用取值的对应关系,使之更趋合理;给出了各等级截面的框架以众值烈度地震作用效应表达的地震组合设计式,使实际应用更为方便。  相似文献   
997.
998.
999.
我国是一个农业大国。农业的发展是国民经济和社会发展的重要因素。复混肥料在农业中的运用也日益广泛。文章研究的凯氏定氮仪法的检测方法与国标方法GB/T8572-2001的原理相同。与国标法比较,总氮含量的绝对误差在0.01%~0.29%之间,极差在0.07%~0.18%之间,检测准确度和精密度都符合国家标准的要求。此方法操作简便快速高效、安全可靠,效果令人满意。  相似文献   
1000.
磷酸酯化淀粉的高效湿法合成研究   总被引:1,自引:0,他引:1  
本研究选用磷酸盐组合物,进行在低温下的淀粉高效磷酸酯化反应。结果表明,在湿法的低温条件下,采用适当的复合磷酸盐及反应促进体系,体系中淀粉浓度在40%~42%,磷酸氢二钠和磷酸二氢钠的比例为0.5,复合盐用量15%,pH保持在5~6之间,50℃反应5 h,Gx16在1%~5%的用量,可以显著提高淀粉的磷酸酯化程度(以结合磷含量表示),同时由于反应效率的提高,使湿法的反应均匀性,残留磷酸盐含量可控性,流程简洁、方便等优势得以突出,对比现实的生产工艺,该方法在稳定质量、节能降耗、减少污染排放等方面都极具优势,有重要的推广价值。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号